Linda D Pegram, MD | |
601 Childrens Ln, Norfolk, VA 23507-1910 | |
(757) 668-7007 | |
(757) 668-8658 |
Full Name | Linda D Pegram |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 601 Childrens Ln, Norfolk, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023064664 | NPI | - | NPPES |
002963700 | Medicaid | MD | |
010061709 | Medicaid | VA | |
8906654 | Medicaid | NC | |
0101236215 | Other | VA | BOARD OF MEDICINE LICENSE TO PRACTICE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0207X | Pediatrics - Pediatric Hematology-oncology | 0101236215 (Virginia) | Primary |
208000000X | Pediatrics | 0101236215 (Virginia) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Linda D Pegram, MD 811 Redgate Ave, Norfolk, VA 23507-1515 Ph: (757) 668-7007 | Linda D Pegram, MD 601 Childrens Ln, Norfolk, VA 23507-1910 Ph: (757) 668-7007 |
News Archive
Protein Sciences Corporation announced that in a rare move, the FDA is granting exclusivity to Flublok for a period of 12 years. Flublok is the first vaccine awarded this very important status, demonstrating Flublok as a unique and game changing influenza vaccine.
The threat of disease transmission from conservationists moving wild animals between habitats or back into the wild needs to be urgently assessed to minimize risk.
Pfizer Inc. and Protalix BioTherapeutics, Inc. today announced the submission of a Marketing Authorization Application to the European Medicines Agency for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD)for the treatment of Gaucher disease. Taliglucerase alfa was granted Orphan Designation by the European Commission for the treatment of Gaucher disease on March 23, 2010.
Scientists from Scientific and Educational Center & Smart Materials and Biomedical Applications under the leadership of Kateryna Levada together with colleagues from Center for Immunology and Cellular Biotechnology of the Immanuel Kant Baltic Federal University conducted a joint interdisciplinary study on the development of a new method for treating leukemia using nanomaterials.
› Verified 8 days ago
Joshua Wayne Gollub, Pediatrics Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7000 | |
Stephen C. Restaino, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7179 Fax: 757-668-9810 | |
Michael Lee Smith, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7456 Fax: 757-668-9255 | |
Phyllis R. Hope, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7456 Fax: 757-668-9255 | |
Ernette Yvonne Benson-foulk, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6345 Center Dr, Building 14, Norfolk, VA 23502 Phone: 757-461-4027 Fax: 757-461-8821 | |
Monica G Baker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7456 Fax: 757-668-9255 |